Home » Newsletters » BioWorld Science

BioWorld Science

May 29, 2019

View Archived Issues

Glial dysfunction is part of chemo brain

TLRs in DIO

"R-AI-diologist" can outperform radiologists in lung cancer screening

In infection, T cells are cachexia drivers

Food antigens drive IgE antibody elevation if no commensals present

SNG-001 for virus-induced exacerbations of lung disease

Enrollment opens in phase III study of HLX-10 in esophageal squamous cell carcinoma

Soligenix obtains support to study IDRs as bacterial threat countermeasures

Mutation in mevalonate kinase found in porokeratosis ptychotropica

Integral Molecular achieves milestone in Daiichi Sankyo immuno-oncology collaboration

Ziopharm and NCI sign T-cell technology licensing agreement

Bristol-Myers Squibb patents farnesoid X receptor agonists

ProMIS identifies antibody candidates that selectively bind toxic oligomers of tau for Alzheimer's

Researchers develop new murine model of dystrophic epidermolysis bullosa-squamous cell carcinoma

AbbVie and Calico Life Sciences jointly describe EIF2B activators

Idorsia prepares and tests antibacterial compounds

P2X3 and/or P2X2/3 receptor antagonists described in Beijing Tide Pharmaceutical patent

AiCuris reports agents for the treatment of HBV infections

In vivo antitumoral activity seen with mixture of cytokine-encoding mRNAs

FDA approves Revlimid with rituximab for previously treated FL and marginal zone lymphoma

Zynerba initiates phase II trial of Zygel to treat behavioral symptoms in 22q11.2 deletion syndrome

Eli Lilly divulges BTK inhibitors in recent patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...